View Item 

Show simple item record

Prognostic importance of left ventricular mechanical dyssynchrony in heart failure with preserved ejection fraction
dc.contributor.authorBiering‐sørensen, Tor
dc.contributor.authorShah, Sanjiv J.
dc.contributor.authorAnand, Inder
dc.contributor.authorSweitzer, Nancy
dc.contributor.authorClaggett, Brian
dc.contributor.authorLiu, Li
dc.contributor.authorPitt, Bertram
dc.contributor.authorPfeffer, Marc A.
dc.contributor.authorSolomon, Scott D.
dc.contributor.authorShah, Amil M.
dc.date.accessioned2017-10-05T18:19:45Z
dc.date.available2018-11-01T16:42:01Zen
dc.date.issued2017-08
dc.identifier.citationBiering‐sørensen, Tor ; Shah, Sanjiv J.; Anand, Inder; Sweitzer, Nancy; Claggett, Brian; Liu, Li; Pitt, Bertram; Pfeffer, Marc A.; Solomon, Scott D.; Shah, Amil M. (2017). "Prognostic importance of left ventricular mechanical dyssynchrony in heart failure with preserved ejection fraction." European Journal of Heart Failure 19(8): 1043-1052.
dc.identifier.issn1388-9842
dc.identifier.issn1879-0844
dc.identifier.urihttps://hdl.handle.net/2027.42/138381
dc.publisherJohn Wiley & Sons, Ltd
dc.subject.otherSpironolactone
dc.subject.otherPreserved left ventricular function
dc.subject.otherHeart ventricles
dc.subject.otherHeart failure
dc.subject.otherClinical trial
dc.subject.otherDyssynchrony
dc.titlePrognostic importance of left ventricular mechanical dyssynchrony in heart failure with preserved ejection fraction
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelCardiovascular Medicine
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/138381/1/ejhf789.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/138381/2/ejhf789_am.pdf
dc.identifier.doi10.1002/ejhf.789
dc.identifier.sourceEuropean Journal of Heart Failure
dc.identifier.citedreferenceNahlawi M, Waligora M, Spies SM, Bonow RO, Kadish AH, Goldberger JJ. Left ventricular function during and after right ventricular pacing. J Am Coll Cardiol 2004; 44: 1883 â 1888.
dc.identifier.citedreferenceKraigherâ Krainer E, Shah AM, Gupta DK, Santos A, Claggett B, Pieske B, Zile MR, Voors AA, Lefkowitz MP, Packer M, McMurray JJV, Solomon SD, PARAMOUNT Investigators. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction. J Am Coll Cardiol 2014; 63: 447 â 456.
dc.identifier.citedreferenceBland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307 â 310.
dc.identifier.citedreferenceCuzick J. A Wilcoxonâ type test for trend. Stat Med 1985; 4: 87 â 90.
dc.identifier.citedreferencePouleur AC, Knappe D, Shah AM, Uno H, Bourgoun M, Foster E, McNitt S, Hall WJ, Zareba W, Goldenberg I, Moss AJ, Pfeffer MA, Solomon SD, MADITâ CRT Investigators. Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADITâ CRT trial. Eur Heart J 2011; 32: 1720 â 1729.
dc.identifier.citedreferenceRuschitzka F, Abraham WT, Singh JP, Bax JJ, Borer JS, Brugada J, Dickstein K, Ford I, Gorcsan J 3rd, Gras D, Krum H, Sogaard P, Holzmeister J, EchoCRT Study Group. Cardiacâ resynchronization therapy in heart failure with a narrow QRS complex. N Engl J Med 2013; 369: 1395 â 1405.
dc.identifier.citedreferenceTan YT, Wenzelburger FW, Sanderson JE, Leyva F. Exerciseâ induced torsional dyssynchrony relates to impaired functional capacity in patients with heart failure and normal ejection fraction. Heart 2013; 99: 259 â 266.
dc.identifier.citedreferenceBaltabaeva A, Marciniak M, Bijnens B, Moggridge J, He FJ, Antonios TF, MacGregor GA, Sutherland GR. Regional left ventricular deformation and geometry analysis provides insights in myocardial remodelling in mild to moderate hypertension. Eur J Echocardiogr 2008; 9: 501 â 508.
dc.identifier.citedreferenceBauer M, Cheng S, Unno K, Lin FC, Liao R. Regional cardiac dysfunction and dyssynchrony in a murine model of afterload stress. PLoS One 2013; 8:e59915.
dc.identifier.citedreferenceSolomon SD, Zile M, Pieske B, Voors A, Shah A, Kraigherâ Krainer E, Shi V, Bransford T, Takeuchi M, Gong J, Lefkowitz M, Packer M, McMurray JJ, Prospective comparison of ARNI with ARB on Management Of heart failUre with preserved ejectioN fracTion (PARAMOUNT) Investigators. The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 doubleâ blind randomised controlled trial. Lancet 2012; 380: 1387 â 1395.
dc.identifier.citedreferenceKnappe D, Pouleur AC, Shah AM, Cheng S, Uno H, Hall WJ, Bourgoun M, Foster E, Zareba W, Goldenberg I, McNitt S, Pfeffer MA, Moss AJ, Solomon SD, Multicenter Automatic Defibrillator Implantation Trialâ Cardiac Resynchronization Therapy Investigators. Dyssynchrony, contractile function, and response to cardiac resynchronization therapy. Circ Heart Fail 2011; 4: 433 â 440.
dc.identifier.citedreferenceKutyifa V, Pouleur Aâ C, Knappe D, Alâ Ahmad A, Gibinski M, Wang PJ, McNitt S, Merkely B, Goldenberg I, Solomon SD, Moss AJ, Zareba W. Dyssynchrony and the risk of ventricular arrhythmias. JACC Cardiovasc Imaging 2013; 6: 432 â 444.
dc.identifier.citedreferenceMollema SA, Liem SS, Suffoletto MS, Bleeker GB, van der Hoeven BL, van de Veire NR, Boersma E, Holman ER, van der Wall EE, Schalij MJ, Gorcsan J, Bax JJ. Left ventricular dyssynchrony acutely after myocardial infarction predicts left ventricular remodeling. J Am Coll Cardiol 2007; 50: 1532 â 1540.
dc.identifier.citedreferenceDonal E, Lund L, Linde C, Daubert JC, KaRen investigators. Is cardiac resynchronization therapy an option in heart failure patients with preserved ejection fraction? Justification for the ongoing KaRen project. Arch Cardiovasc Dis 2010; 103: 404 â 410.
dc.identifier.citedreferenceDonal E, Lund LH, Oger E, Hage C, Persson H, Reynaud A, Ennezat PV, Bauer F, Drouet E, Linde C, Daubert C, KaRen investigators. New echocardiographic predictors of clinical outcome in patients presenting with heart failure and a preserved left ventricular ejection fraction: a subanalysis of the Ka (Karolinska) Ren (Rennes) Study. Eur J Heart Fail 2015; 17: 680 â 688.
dc.identifier.citedreferenceSolomon SD, Foster E, Bourgoun M, Shah A, Viloria E, Brown MW, Hall WJ, Pfeffer MA, Moss AJ, MADITâ CRT Investigators. Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapy. Circulation 2010; 122: 985 â 992.
dc.identifier.citedreferenceYu CM, Chan JY, Zhang Q, Omar R, Yip GWâ K, Hussin A, Fang F, Lam KH, Chan HC, Fung JW. Biventricular pacing in patients with bradycardia and normal ejection fraction. N Engl J Med 2009; 361: 2123 â 2134.
dc.identifier.citedreferenceSantos ABS, Roca GQ, Claggett B, Sweitzer NK, Shah SJ, Anand IS, Fang JC, Zile MR, Pitt B, Solomon SD, Shah AM. Prognostic relevance of left atrial dysfunction in heart failure with preserved ejection fraction. Circ Heart Fail 2016; 9:e002763.
dc.identifier.citedreferenceFreed BH, Daruwalla V, Cheng JY, Aguilar FG, Beussink L, Choi A, Klein DA, Dixon D, Baldridge A, Rasmussenâ Torvik LJ, Maganti K, Shah SJ. Prognostic utility and clinical significance of cardiac mechanics in heart failure with preserved ejection fraction: importance of left atrial strain. Circ Cardiovasc Imaging 2016; 9:e003754.
dc.identifier.citedreferenceGorcsan J 3rd, Tanaka H. Echocardiographic assessment of myocardial strain. J Am Coll Cardiol 2011; 58: 1401 â 1413.
dc.identifier.citedreferenceRisum N, Williams ES, Khouri MG, Jackson KP, Olsen NT, Jons C, Storm KS, Velazquez EJ, Kisslo J, Bruun NE, Sogaard P. Mechanical dyssynchrony evaluated by tissue Doppler crossâ correlation analysis is associated with longâ term survival in patients after cardiac resynchronization therapy. Eur Heart J 2013; 34: 48 â 56.
dc.identifier.citedreferenceRisum N, Tayal B, Hansen TF, Bruun NE, Jensen MT, Lauridsen TK, Saba S, Kisslo J, Gorcsan J, Sogaard P. Identification of typical left bundle branch block contraction by strain echocardiography is additive to electrocardiography in prediction of longâ term outcome after cardiac resynchronization therapy. J Am Coll Cardiol 2015; 66: 631 â 641.
dc.identifier.citedreferenceHaugaa KH, Goebel B, Dahlslett T, Meyer K, Jung C, Lauten A, Figulla HR, Poerner TC, Edvardsen T. Risk assessment of ventricular arrhythmias in patients with nonischemic dilated cardiomyopathy by strain echocardiography. J Am Soc Echocardiogr 2012; 25: 667 â 673.
dc.identifier.citedreferenceHaugaa KH, Grenne BL, Eek CH, Ersbøll M, Valeur N, Svendsen JH, Florian A, Sjøli B, Brunvand H, Køber L, Voigt JU, Desmet W, Smiseth OA, Edvardsen T. Strain echocardiography improves risk prediction of ventricular arrhythmias after myocardial infarction. JACC Cardiovasc Imaging 2013; 6: 841 â 850.
dc.identifier.citedreferenceBieringâ Sørensen T, Olsen FJ, Storm K, Fritzâ Hansen T, Olsen NT, Jøns C, Vinther M, Søgaard P, Risum N. Prognostic value of tissue Doppler imaging for predicting ventricular arrhythmias and cardiovascular mortality in ischaemic cardiomyopathy. Eur Heart J Cardiovasc Imaging 2016; 17: 722 â 731.
dc.identifier.citedreferenceNegishi K, Negishi T, Zardkoohi O, Ching EA, Basu N, Wilkoff BL, PopoviÄ ZB, Marwick TH. Left atrial booster pump function is an independent predictor of subsequent lifeâ threatening ventricular arrhythmias in nonâ ischaemic cardiomyopathy. Eur Heart J Cardiovasc Imaging 2016; 17: 1153 â 1160.
dc.identifier.citedreferenceBieringâ Sørensen T, Knappe D, Pouleur Aâ C, Claggett B, Wang PJ, Moss AJ, Solomon SD, Kutyifa V. Regional longitudinal deformation improves prediction of ventricular tachyarrhythmias in patients with heart failure with reduced ejection fraction: a MADITâ CRT substudy (Multicenter Automatic Defibrillator Implantation Trialâ Cardiac Resynchronization Therapy). Circ Cardiovasc Imaging 2017; 10:e005096.
dc.identifier.citedreferenceShah AM, Pfeffer MA. The many faces of heart failure with preserved ejection fraction. Nat Rev Cardiol 2012; 9: 555 â 556.
dc.identifier.citedreferenceXiao HB, Roy C, Fujimoto S, Gibson DG. Natural history of abnormal conduction and its relation to prognosis in patients with dilated cardiomyopathy. Int J Cardiol 1996; 53: 163 â 170.
dc.identifier.citedreferenceMoss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NAM, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W, MADITâ CRT Trial Investigators. Cardiacâ resynchronization therapy for the prevention of heartâ failure events. N Engl J Med 2009; 361: 1329 â 1338.
dc.identifier.citedreferenceGorcsan J 3rd, Sogaard P, Bax JJ, Singh JP, Abraham WT, Borer JS, Dickstein K, Gras D, Krum H, Brugada J, Robertson M, Ford I, Holzmeister J, Ruschitzka F. Association of persistent or worsened echocardiographic dyssynchrony with unfavourable clinical outcomes in heart failure patients with narrow QRS width: a subgroup analysis of the EchoCRT trial. Eur Heart J 2016; 37: 49 â 59.
dc.identifier.citedreferenceBhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, Gong Y, Liu PP. Outcome of heart failure with preserved ejection fraction in a populationâ based study. N Engl J Med 2006; 355: 260 â 269.
dc.identifier.citedreferenceOwan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006; 355: 251 â 259.
dc.identifier.citedreferenceJoseph J, Claggett BC, Anand IS, Fleg JL, Huynh T, Desai AS, Solomon SD, O’Meara E, Mckinlay S, Pitt B, Pfeffer MA, Lewis EF. QRS duration is a predictor of adverse outcomes in heart failure with preserved ejection fraction. JACC Heart Fail 2016; 4: 477 â 486.
dc.identifier.citedreferenceSantos ABS, Kraigherâ Krainer E, Bello N, Claggett B, Zile MR, Pieske B, Voors AA, McMurray JJ, Packer M, Bransford T, Lefkowitz M, Shah AM, Solomon SD. Left ventricular dyssynchrony in patients with heart failure and preserved ejection fraction. Eur Heart J 2014; 35: 42 â 47.
dc.identifier.citedreferenceMenet A, Greffe L, Ennezat PV, Delelis F, Guyomar Y, Castel AL, Guiot A, Graux P, Tribouilloy C, Marechaux S. Is mechanical dyssynchrony a therapeutic target in heart failure with preserved ejection fraction? Am Heart J 2014; 168: 909 â 916.e1.
dc.identifier.citedreferenceDesai AS, Lewis EF, Li R, Solomon SD, Assmann SF, Boineau R, Clausell N, Diaz R, Fleg JL, Gordeev I, McKinlay S, O’Meara E, Shaburishvili T, Pitt B, Pfeffer MA. Rationale and design of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial: a randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction. Am Heart J 2011; 162: 966 â 972.e10.
dc.identifier.citedreferenceShah SJ, Heitner JF, Sweitzer NK, Anand IS, Kim Hâ Y, Harty B, Boineau R, Clausell N, Desai AS, Diaz R, Fleg JL, Gordeev I, Lewis EF, Markov V, O’Meara E, Kobulia B, Shaburishvili T, Solomon SD, Pitt B, Pfeffer MA, Li R. Baseline characteristics of patients in the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial. Circ Heart Fail 2013; 6: 184 â 192.
dc.identifier.citedreferencePitt B, Pfeffer MA, Assmann SF, Boineau R, Anand IS, Claggett B, Clausell N, Desai AS, Diaz R, Fleg JL, Gordeev I, Harty B, Heitner JF, Kenwood CT, Lewis EF, O’Meara E, Probstfield JL, Shaburishvili T, Shah SJ, Solomon SD, Sweitzer NK, Yang S, McKinlay SM, TOPCAT Investigators. Spironolactone for heart failure with preserved ejection fraction. N Engl J Med 2014; 370: 1383 â 1392.
dc.identifier.citedreferenceShah AM, Shah SJ, Anand IS, Sweitzer NK, O’Meara E, Heitner JF, Sopko G, Li G, Assmann SF, McKinlay SM, Pitt B, Pfeffer MA, Solomon SD, TOPCAT Investigators. Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial. Circ Heart Fail 2014; 7: 104 â 115.
dc.identifier.citedreferenceShah AM, Claggett B, Sweitzer NK, Shah SJ, Anand IS, Liu L, Pitt B, Pfeffer MA, Solomon SD. Prognostic importance of impaired systolic function in heart failure with preserved ejection fraction and the impact of spironolactone. Circulation 2015; 132: 402 â 414.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
ejhf789.pdf
Size:
486.1KB
Format:
PDF
View/Open
Name:
ejhf789_am.pdf
Size:
862.5KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.